INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 47m ago
HOUSE PTR7m ago
SEC 13F7m ago
ROBINHOOD CHAIN7m ago
Public company

PTCTPTC THERAPEUTICS, INC.

CIK 0001070081

EDGAR filingsOpen in network
Disclosed transactions22
Buys / sells0 / 11
Max Insider Score27
Connections11with evidence

PTCT · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
4
KB
Klein Matthew B.Director, CHIEF EXECUTIVE OFFICER
PTCTPTC THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$202K
2,850 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Connected organizationevidence
    PTC THERAPEUTICS, INC. POLITICAL ACTION COMMITTEE (PTC-PAC)FEC Form 1 connected organization: PTC THERAPEUTICS, INC. (exact legal-name match) · Nov 4, 2026
  • ← Lobbied forevidence
    BGR GOVERNMENT AFFAIRSLDA Q2 2026 second quarter · Health issues · Aug 26, 2026
  • ← Lobbied forevidence
    LMH STRATEGIC SOLUTIONS
8
GS
Golden Lee ScottEVP & CHIEF MEDICAL OFFICER
PTCTPTC THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL
$56K
829 sh
Apr 2, 2026
Apr 6, 2026
traded Apr 2, 2026
+4d
SEC FORM 4

Evidence

0
CC
Chutter Jessica CarolineDirector
PTCTPTC THERAPEUTICS, INC.
Grant or award · 10b5-1 plan
A—
2,896 sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC FORM 4

Evidence

0
CC
Chutter Jessica CarolineDirector
PTCTPTC THERAPEUTICS, INC.
Grant or award · 10b5-1 plan
A—
4,000 sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC FORM 4

Evidence

11
CC
Chutter Jessica CarolineDirector
PTCTPTC THERAPEUTICS, INC.
Grant or award · 10b5-1 plan
A—
3,333 sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC FORM 4

Evidence

0
CC
Chutter Jessica CarolineDirector
PTCTPTC THERAPEUTICS, INC.
Grant or award · 10b5-1 plan
A—
3,475 sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC FORM 4

Evidence

4
GP
Gravier PierreCHIEF FINANCIAL OFFICER
PTCTPTC THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$208K
2,992 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

18
UM
Utter Christine MarieSVP, CHIEF ACCOUNTING OFFICER
PTCTPTC THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$79K
1,034 sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC FORM 4

Evidence

14
KB
Klein Matthew B.Director, CHIEF EXECUTIVE OFFICER
PTCTPTC THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$192K
2,514 sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC FORM 4

Evidence

18
GP
Gravier PierreCHIEF FINANCIAL OFFICER
PTCTPTC THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$165K
2,139 sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC FORM 4

Evidence

14
KB
Klein Matthew B.Director, CHIEF EXECUTIVE OFFICER
PTCTPTC THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$234K
3,016 sh
Jan 7, 2026Jan 8, 2026
traded Jan 7, 2026
+1dSEC FORM 4

Evidence

17
KB
Klein Matthew B.Director, CHIEF EXECUTIVE OFFICER
PTCTPTC THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$396K
5,149 sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC FORM 4

Evidence

9
GP
Gravier PierreCHIEF FINANCIAL OFFICER
PTCTPTC THERAPEUTICS, INC.
Grant or award
A—
50.0K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC FORM 4

Evidence

17
GP
Gravier PierreCHIEF FINANCIAL OFFICER
PTCTPTC THERAPEUTICS, INC.
Grant or award
A—
20.0K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC FORM 4

Evidence

27
KB
Klein Matthew B.Director, CHIEF EXECUTIVE OFFICER
PTCTPTC THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$620K
8,089 sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC FORM 4

Evidence

0
RE
Reeve EmmaDirector
PTCTPTC THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M—
10.0K sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC FORM 4

Evidence

19
RE
Reeve EmmaDirector
PTCTPTC THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$795K
10.0K sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC FORM 4

Evidence

13
RE
Reeve EmmaDirector
PTCTPTC THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M$512K
10.0K sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC FORM 4

Evidence

16
OS
Okey StephanieDirector
PTCTPTC THERAPEUTICS, INC.
Gift
G—
867 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC FORM 4

Evidence

17
RE
Reeve EmmaDirector
PTCTPTC THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M$341K
7,333 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC FORM 4

Evidence

0
RE
Reeve EmmaDirector
PTCTPTC THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M—
7,333 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC FORM 4

Evidence

23
RE
Reeve EmmaDirector
PTCTPTC THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$546K
7,333 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC FORM 4

Evidence

LDA Q1 2026 first quarter · Health issues · Aug 26, 2026
  • ← Insider ofevidence
    Golden Lee ScottEVP & CHIEF MEDICAL OFFICER · Apr 6, 2026
  • ← Insider ofevidence
    Chutter Jessica CarolineDirector · Mar 26, 2026
  • ← Insider ofevidence
    Utter Christine MarieSVP, CHIEF ACCOUNTING OFFICER · Jan 12, 2026
  • ← Insider ofevidence
    Gravier PierreCHIEF FINANCIAL OFFICER · Jan 6, 2026
  • ← Insider ofevidence
    Klein Matthew B.Director, CHIEF EXECUTIVE OFFICER · Jan 2, 2026
  • ← Insider ofevidence
    Okey StephanieDirector · Nov 21, 2025
  • ← Insider ofevidence
    Reeve EmmaDirector · Nov 14, 2025

    • Lobbying

    $560K reported · de-duplicated
    2026 Q2 $170K in-house2026 Q1 $390K in-house
    • BGR GOVERNMENT AFFAIRS$50K2026 Q1 · posted Aug 26, 2026 · Health issues
    • LMH STRATEGIC SOLUTIONS$50K2026 Q2 · posted Aug 26, 2026 · Health issues
    • In-house report$390K2026 Q1 · posted Aug 26, 2026 · Health issues, MED, Medicare/Medicaid, Taxation, Trade
    • BGR GOVERNMENT AFFAIRS$50K2026 Q2 · posted Aug 26, 2026 · Health issues
    • In-house report$170K2026 Q2 · posted Aug 26, 2026 · Health issues, MED, Medicare/Medicaid, Taxation, Trade
    • LMH STRATEGIC SOLUTIONS$50K2026 Q1 · posted Aug 26, 2026 · Health issues

    Connected PAC contributions

    FEC · direct to members
    • Doris O. MatsuiD$10KPTC THERAPEUTICS, INC. POLITICAL ACTION COMMITTEE (PTC-PAC)
    • H. Morgan GriffithR$9,500PTC THERAPEUTICS, INC. POLITICAL ACTION COMMITTEE (PTC-PAC)
    • Scott H. PetersD$7,500PTC THERAPEUTICS, INC. POLITICAL ACTION COMMITTEE (PTC-PAC)
    • John JoyceR$6,000PTC THERAPEUTICS, INC. POLITICAL ACTION COMMITTEE (PTC-PAC)
    • Josh GottheimerD$5,000PTC THERAPEUTICS, INC. POLITICAL ACTION COMMITTEE (PTC-PAC)
  • Thomas H. Kean, Jr.R$5,000PTC THERAPEUTICS, INC. POLITICAL ACTION COMMITTEE (PTC-PAC)
  • Raul RuizD$5,000PTC THERAPEUTICS, INC. POLITICAL ACTION COMMITTEE (PTC-PAC)
  • Gus M. BilirakisR$4,000PTC THERAPEUTICS, INC. POLITICAL ACTION COMMITTEE (PTC-PAC)
  • Troy BaldersonR$3,500PTC THERAPEUTICS, INC. POLITICAL ACTION COMMITTEE (PTC-PAC)
  • Nanette Diaz BarragánD$3,500PTC THERAPEUTICS, INC. POLITICAL ACTION COMMITTEE (PTC-PAC)
  • Jake AuchinclossD$3,000PTC THERAPEUTICS, INC. POLITICAL ACTION COMMITTEE (PTC-PAC)
  • Ami BeraD$3,000PTC THERAPEUTICS, INC. POLITICAL ACTION COMMITTEE (PTC-PAC)